Discover 2,409 paid clinical trials in Naperville, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,409
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
for
Extensive Stage Small Cell Lung Cancer
Location: Chicago IL, Ann Arbor MI, Sioux Falls SD, Houston TX,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT06598306
Phase 1, Recruiting
Parasitic Ulcer Treatment Trial
for
Acanthamoeba Keratitis
Location: Chicago IL, Iowa City IA, Pittsburgh PA, Baltimore MD,
Sponsor: Jeremy Keenan, MD, MPH
Sex: All
Age: 8+
Code: NCT06213649
Phase 3, Recruiting
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Location: Chicago IL, Ann Arbor MI, New York NY, Jacksonville FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06401356
Phase 3, Recruiting
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
for
Heart Failure With Reduced Ejection Fraction
Location: Chicago IL, New Haven CT, Aurora CO, Salt Lake City UT,
Sponsor: University of Colorado, Denver
Sex: All
Age: 18+
Code: NCT06526988
Recruiting
Analysis of Human ALS Tissues and Registry of ALS Patients
for
Amyotrophic Lateral Sclerosis
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18 - 70+
Code: NCT05067179
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Evanston IL, Grand Rapids MI, Indianapolis IN,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase 3, Recruiting
ATEMPT 2.0: Adjuvant T-DM1 vs TH
for
Breast Cancer, HER2-positive Breast Cancer
Location: Chicago IL, Columbus OH, Nashville TN, Pittsburgh PA,
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04893109
Phase 2, Recruiting
Fall Prevention Program for Non-ambulatory Wheeled Mobility Device Users Living With MS
for
Multiple Sclerosis
Location: Chicago IL, Urbana IL, Atlanta GA
Sponsor: University of Illinois at Urbana-Champaign
Sex: All
Age: 18+
Code: NCT03705364
Recruiting
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
for
Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer
Location: Chicago IL, Madison WI, Pittsburgh PA, Philadelphia PA,
Sponsor: University of Colorado, Denver
Sex: Female
Age: 18 - 70+
Code: NCT05887609
Phase 2, Recruiting
Fisetin to Reduce Senescence and Mobility Impairment in PAD
for
Peripheral Arterial Disease, Aging,
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 50+
Code: NCT06399809
Phase 2, Recruiting
SPIROMICS Study of Early COPD Progression (SOURCE)
for
COPD, Early-Onset
Location: Chicago IL, Iowa City IA, Ann Arbor MI,
Sponsor: University of Massachusetts, Worcester
Sex: All
Age: 30 - 55
Code: NCT05033990
Recruiting
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
for
Knee Osteoarthritis
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 41+
Code: NCT06245109
Recruiting
My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
for
Type 2 Diabetes, Sleep, Stress
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 21 - 70+
Code: NCT05208164
Recruiting
Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
Location: Chicago IL, Boston MA, Houston TX, San Francisco CA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04883671
Recruiting
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: Evanston IL, Milwaukee WI, Indianapolis IN,
Sponsor: Volastra Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05902988
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
for
Solid Tumor
Location: Chicago IL, Augusta GA, New York NY, Tampa FL,
Sponsor: Eisai Inc.
Sex: All
Age: 18+
Code: NCT04300556
Phase 1, Phase 2, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Chicago IL, Grand Rapids MI, Ann Arbor MI, St Louis MO,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase 1, Recruiting
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
for
Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2,
Location: Chicago IL, Ann Arbor MI, Atlanta GA, Baltimore MD,
Sponsor: Lauren Moore
Sex: All
Age: 6+
Code: NCT01060371
Recruiting
Tocilizumab for Acute Chest Syndrome
for
Sickle Cell Disease, Acute Chest Syndrome
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 12+
Code: NCT05640271
Phase 2, Recruiting
Mosaic Trial for Stem Cell Transplant Recipients
for
Hematologic Malignancy, Stem Cell Transplant,
Location: Chicago IL, Washington D.C. DC, Nutley NJ